{
    "clinical_study": {
        "@rank": "30099", 
        "arm_group": [
            {
                "arm_group_label": "D5NS at 125 mL/hr", 
                "arm_group_type": "Experimental", 
                "description": "5% dextrose in normal saline at 125 mL/hr"
            }, 
            {
                "arm_group_label": "D2.5NS at 250mL/hr", 
                "arm_group_type": "Experimental", 
                "description": "2.5% dextrose in normal saline at 250 mL/hr"
            }, 
            {
                "arm_group_label": "NS at 250mL/hr", 
                "arm_group_type": "Experimental", 
                "description": "Normal saline at 250mL/hr"
            }
        ], 
        "brief_summary": {
            "textblock": "This randomized controlled trial aims to compare three groups of intravenous fluids and\n      their impact on labor: 1) 125 mL/hr of 5% dextrose in normal saline 2) 250 mL/hr of normal\n      saline 3) 250 mL/hr of 5% dextrose in normal saline"
        }, 
        "brief_title": "Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas", 
        "condition": [
            "Length of Labor", 
            "Second Stage of Labor", 
            "Intravenous Hydration of Labor"
        ], 
        "detailed_description": {
            "textblock": "Currently, patients who arrive to labor and delivery automatically receive IV fluid\n      hydration as part of a standard order set.  The current default IV fluid order is 125mL/hr\n      of 5% dextrose, either in normal saline or lactated ringers.\n\n      Any patient delivering for the first time presenting to labor and delivery in active labor\n      will be screened.  If they meet inclusion requirements they will be offered enrollment.\n\n      Subjects will be blindly randomized to receive one of three different types of IV fluids:\n\n        1. 5% dextrose Normal saline (Normal saline plus 5g/dl of glucose) at 125 mL/hr (the\n           current LBMMC default inpatient IV order set)\n\n        2. Normal saline (a solution containing sodium and chloride) at 250 mL/hr\n\n        3. 2.5% dextrose Normal saline at 125 mL/hr\n\n             -  Management of labor will be at the discretion of the attending physician(s).\n\n             -  Maternal outcomes to be measured include: 1) total amount of IV fluids\n                administered, 2) length of labor, 3) epidural use, 4) oxytocin use, 5) mode of\n                delivery, 6) development of maternal infections or other morbidity such as\n                postpartum hemorrhage.\n\n             -  Neonatal outcomes to be measured include: 1) birth weight, 2) Apgar scores,  3)\n                hospital course (nursery placement and length of stay), 4) need for treatment of\n                jaundice."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  \u2022 Primiparous\n\n               -  Singleton gestation\n\n               -  Vertex presentation\n\n               -  Spontaneous active labor with or without pitocin augmentation\n\n               -  Gestational age > 36 weeks\n\n               -  Cervical dilation 3 to 5 cm with or without ruptured membranes\n\n        Exclusion Criteria:\n\n          -  \u2022 Multiparous\n\n               -  Pregestational or gestational diabetes mellitus\n\n               -  Preeclampsia at admission\n\n               -  Previous cesarean section\n\n               -  Non-vertex presentation\n\n               -  Multiple gestation\n\n               -  Chorioamnionitis at admission\n\n               -  Intrauterine growth restriction (< 10th percentile)\n\n               -  Patients admitted for induction\n\n               -  BMI > 50"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01904617", 
            "org_study_id": "025-11"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "D5NS at 125 mL/hr", 
                    "D2.5NS at 250mL/hr"
                ], 
                "intervention_name": "Dextrose", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "D5NS at 125 mL/hr", 
                    "D2.5NS at 250mL/hr", 
                    "NS at 250mL/hr"
                ], 
                "intervention_name": "Normal Saline", 
                "intervention_type": "Other", 
                "other_name": "Intravenous fluids, normal saline"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Length of labor", 
            "second stage of labor", 
            "intravenous hydration of labor", 
            "intravenous glucose"
        ], 
        "lastchanged_date": "January 27, 2014", 
        "location": {
            "contact": {
                "email": "dcaballero@memorialcare.org", 
                "last_name": "Deysi Caballero, LVN", 
                "phone": "562-933-2755"
            }, 
            "facility": {
                "address": {
                    "city": "Long Beach", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90806"
                }, 
                "name": "Long Beach Memorial Medical Center"
            }, 
            "investigator": {
                "last_name": "Vineet Shrivastava, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "3", 
        "official_title": "A Randomized Controlled Trial on the Effects of Rate and/or Presence of Dextrose on the Labor Course of Nulliparas", 
        "overall_contact": {
            "email": "dcaballero@memorialcare.org", 
            "last_name": "Deysi Caballero, LVN", 
            "phone": "562-933-2755"
        }, 
        "overall_official": {
            "affiliation": "Long Beach Memorial Medical Center", 
            "last_name": "Vineet Shrivastava, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Length of labor", 
            "safety_issue": "No", 
            "time_frame": "Time from fluid initiation to delivery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01904617"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Time of second stage of labor", 
            "safety_issue": "No", 
            "time_frame": "Time from initiation of pushing to delivery"
        }, 
        "source": "MemorialCare Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "MemorialCare Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}